AlbaCore Capital inks financing partnership with MindMaze

European credit investment firm AlbaCore Capital Group has invested $125 million in Swiss firm MindMaze, a player in the digital neurotherapeutics market, delivering seamless digital assessments and therapeutics over the full continuum of care in over 20 countries, serving thousands of patients suffering from neurological conditions. The company currently collaborates with approximately 90 healthcare providers and has a product portfolio that has received three FDA clearances and four CE marks across eight clinical indications. MindMaze, backed by Mumbai-based Hinduja Group, will use the proceeds to accelerate commercialisation of and enhance market access for, its approved and reimbursed neuro-rehabilitation platform as well as expanding its neuro-restorative portfolio.